Abstract
Current strategies for the treatment of type 2 diabetes mellitus promote individualized plans to achieve target glucose levels on a patient-by-patient basis while minimizing treatment related risks. Maintaining glycemic control over time is a significant challenge because of the progressive nature of diabetes as a result of declining β-cell function. This article identifies complications of non-insulin treatments for diabetes. The major classes of medications are reviewed with special focus on target population, mechanism of action, effect on weight, cardiovascular outcomes and additional class-specific side effects including effects on bone. Effects on β-cell function are also highlighted.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 947-970 |
| Number of pages | 24 |
| Journal | Endocrinology and Metabolism Clinics of North America |
| Volume | 42 |
| Issue number | 4 |
| DOIs | |
| State | Published - Dec 2013 |
| Externally published | Yes |
Keywords
- Cardiovascular outcomes
- Diabetes
- Treatment complications
- β-cell function
ASJC Scopus subject areas
- Endocrinology
- Endocrinology, Diabetes and Metabolism